4//SEC Filing
Morag Eyal 4
Accession 0001493152-23-001824
CIK 0000883975other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 8:27 AM ET
Size
5.8 KB
Accession
0001493152-23-001824
Insider Transaction Report
Form 4
Morag Eyal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-17+35,000→ 35,000 totalExercise: $3.48Exp: 2033-01-17→ Common Stock, par value $0.01 per share (35,000 underlying)
Footnotes (1)
- [F1]The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on July 17, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.
Documents
Issuer
Microbot Medical Inc.
CIK 0000883975
Entity typeother
Related Parties
1- filerCIK 0001805787
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 8:27 AM ET
- Size
- 5.8 KB